Description
Ceritinib
Each capsule contains: Ceritinib. … 150mg.
INDICATION
LuciCer is a kinase inhibitor indicated for the treatment of patients with metastatic nonsmall cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)positive.
DOSAGE AND USE
750 mg orally once daily. Take LuciCer at least 1 hour before or at least 2 hours after a meal.
STORAGE
In a dry place and store at 20°C to 25°C.
MANUFACTURED AND MARKETED BY
LUCIUS PHARMACEUTICALS(LAO) CO., LTD No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos
WARNING
Keep medicine out of reach of Children.Do not administer LuciCer during Pregnancy and Lactation.
Reviews
There are no reviews yet.